Alzheimer disease, familial, type 3
|
0.900 |
Biomarker
|
disease |
BEFREE |
As an alternative gene therapy approach for RCC that would circumvent CAR deficiency, we employed retargeting of replication-incompetent Ad vectors and replication-competent Ad viruses to alpha(v)beta 3 and alpha(v)beta 5 integrins and to the putative Ad3 receptor.
|
12154029 |
2002 |
Alzheimer disease, familial, type 3
|
0.900 |
Biomarker
|
disease |
BEFREE |
We collected blood DNA from 120 late-onset Alzheimer's disease (AD) patients and 115 healthy matched controls and analysed the methylation levels of genes involved in amyloid-beta peptide production (PSEN1 and BACE1), in DNA methylation (DNMT1, DNMT3A and DNMT3B), and in one-carbon metabolism (MTHFR), searching for correlation with age and gender, with biomarkers of one-carbon metabolism (plasma homocysteine, and serum folate and vitamin B12 levels), and with disease status (being healthy or having AD).
|
26079324 |
2015 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
To obtain in vivo information about how PS1 mutations cause AD pathology at such early ages, we characterized the neuropathological phenotype of four PS1-FAD patients from a large Colombian kindred bearing the codon 280 Glu to Ala substitution (Glu280Ala) PS1 mutation.
|
8837617 |
1996 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
All mutations described in the PS-1 gene were found in early-onset Alzheimer's disease (AD) patients.
|
10732806 |
1998 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The genotypic (chi2= 0.92, df = 2, P > 0.1) and allelic (chi2 = 0.01, df = 1, P > 0.1) frequencies of the PS1 polymorphism in the late- and early-onset sporadic AD patients did not differ from those in the controls.
|
11129109 |
2000 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Several leucine>proline substitutions in other PSEN1 transmembrane helices revealed aggressive AD phenotypes.
|
28532645 |
2017 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
As families AD/A and AD/B have very similar AD phenotype our observation of two mutations in functionally different domains suggest that onset age and severity of AD may not be very helpful predictors of the location of putative S182 mutations.
|
8634711 |
1995 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Moreover the average age of onset in AD patients with the PS-1 2/2 genotype is older than that in AD patients with a 1/2 genotype or with a 1/1 genotype.
|
9185685 |
1997 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Four different missense mutations of the PS-1 gene, including a novel mutation, Glu273Ala, were identified in five early onset FAD families and one missense mutation of PS-1 in one isolated AD patient.
|
9804121 |
1998 |
Alzheimer disease, familial, type 3
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We found a brain-region-specific decrease in MAPT promoter methylation in PSEN1 AD patients.
|
26159201 |
2015 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.
|
16546171 |
2006 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial frontotemporal dementia associated with a novel presenilin-1 mutation.
|
12053127 |
2002 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The authors conclude that PSEN1 mutations can be associated with clinical features of frontotemporal dementia.
|
11094121 |
2000 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Alternative transcripts of presenilin-1 associated with frontotemporal dementia.
|
11997713 |
2002 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations.
|
16948293 |
2006 |
Pick Disease of the Brain
|
0.800 |
Biomarker
|
disease |
BEFREE |
DNA methylation was analyzed in selected regions of MAPT, APP, and PSEN1 in the frontal cortex and hippocampus of controls (n=26) and those with Alzheimer disease at Stages I to II (n=17); Alzheimer disease at Stages III to IV (n=15); Alzheimer disease at Stages V to VI (n=12); argyrophilic grain disease (n=10); frontotemporal lobar degeneration linked to tau mutations (n=6); frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions (n=4); frontotemporal lobar degeneration with motor neuron disease (n=3); Pick disease (n=3); Parkinson disease (n=8); dementia with Lewy bodies, pure form (n=5); and dementia with Lewy bodies, common form (n=15).
|
19606065 |
2009 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We investigated the contribution of rare variants in seven genes of known relevance to dementias (β-amyloid precursor protein (APP), PSEN1/2, MAPT (microtubule-associated protein tau), fused in sarcoma (FUS), granulin (GRN) and TAR DNA-binding protein 43 (TDP-43)) to PD and PD plus dementia (PD+D) in a discovery sample of 376 individuals with PD and followed by the genotyping of 25 out of the 27 identified variants with a minor allele frequency <5% in 975 individuals with PD, 93 cases with Lewy body disease on neuropathological examination, 613 individuals with Alzheimer's disease (AD), 182 cases with frontotemporal dementia and 1014 general population controls.
|
25604855 |
2015 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Alternative transcripts of presenilin-1 associated with frontotemporal dementia.
|
11973477 |
2002 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
M146L mutant PS-1 may predispose to both Pick's disease and AD by affecting multiple intracellular pathways involving tau phosphorylation and amyloid metabolism.
|
15622541 |
2005 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Presenilin 1 (PSEN1) gene mutations deterministic for Alzheimer's disease (AD) are associated with marked heterogeneity in clinical phenotype, with behavioral and psychiatric features, parkinsonism, myoclonus, epileptic seizures, spastic paraparesis, frontal behavioral changes suggestive of the phenotype of frontotemporal dementia, aphasia, and cerebellar ataxia being described as well as cognitive decline.
|
23948899 |
2013 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Some PSEN1 mutations are associated with a phenotype fulfilling the clinical criteria of frontotemporal dementia.
|
19276543 |
2009 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in presenilin-1 (PSEN1) cause autosomal dominant Alzheimer's disease and mutations in MAPT cause the familial tauopathy Frontotemporal dementia linked to chromosome 17 (FTDP-17).
|
17071927 |
2006 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques.
|
15122701 |
2004 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic testing confirmed the absence of mutations in the presenilin 1 gene in 1 patient; subsequent testing revealed the R406W tau mutation in both individuals leading to a diagnosis of frontotemporal dementia [F]FDDNP retention broadly correlated with CSF levels of t-tau and p-tau.
|
20683187 |
2011 |
Pick Disease of the Brain
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
PRESENILIN1 (PSEN1) is the major locus for mutations causing familial Alzheimer's disease (FAD) and is also mutated in Pick disease of brain, familial acne inversa and dilated cardiomyopathy.
|
24101600 |
2014 |